Free Trial

ASLAN Pharmaceuticals (ASLN) SEC Filings & 10K Form

ASLAN Pharmaceuticals logo
$0.60 0.00 (0.00%)
As of 04/17/2025

Recent ASLAN Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
6:15 PM
ASLAN Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G
09/06/2024
6:41 AM
ASLAN Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/08/2024
10:36 AM
ASLAN Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G/A
07/17/2024
6:29 AM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
6:29 AM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2024
11:15 PM
ASLAN Pharmaceuticals (Filer)
Form EFFECT
06/14/2024
3:46 PM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2024
3:30 PM
ASLAN Pharmaceuticals (Subject)
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Form F-6 POS
06/12/2024
3:32 PM
ASLAN Pharmaceuticals (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
05/09/2024
6:10 AM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
6:41 AM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
7:29 AM
ASLAN Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ASLN) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners